OMB is filing
comment on this ICR which is part of a proposed rule. Approval for
the changes associated with the rule is not granted at this time.
FDA should resubmit this ICR in conjunction with the final proposed
rule.
Inventory as of this Action
Requested
Previously Approved
07/31/2012
36 Months From Approved
08/31/2012
244,537
0
244,537
294,194
0
294,194
0
0
0
This proposal amends FDAs postmaket
medical device reporting regulations to require that manufacturers,
importers and user facilities submit mandatory reports of
individual medical device adverse events ( MDRs) to the agency in
an electronic fomat that FDA can process, review and
achive.
The burden decrease and cost
increases are associated with the proposed rule to mandate
electronic reporting of medical device adverse advents reporting.
We estimate that the hourly burden will decrease because electronic
reporting reduces industry`s time and cost associated with
transcribing data from internal data management system to paper and
mailing them to the agency. However respondents will incur an
annualized capital/maintenance/operating costs of $373,871.
$2,200,000
No
No
Uncollected
Uncollected
No
Uncollected
Denver Presley
3018271462
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.